Beena Wood, Qinecsa, saw 2025 as an AI superposition in which pharmacovigilence needed better data foundations and regulation ...
It is undeniable that AI tools have shifted from cautious experimentation to widespread adoption, and clinicians are actively ...
AvePoint’s own research has found that only 30% classify data effectively, in a way that shields it from improper access or exposure, while IBM has found that nearly all (97%) of organizations lack AI ...
As for why SOA faltered, Holt points to heavyweight standards, orchestration and performance issues, lack of reuse, cultural ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback